Stockreport

Immuneering GAAP EPS of -$0.58 [Seeking Alpha]

Immuneering Corporation - Class A  (IMRX) 
PDF Immuneering press release NASDAQ: IMRX ): Q4 GAAP EPS of -$0.58. Cash, cash equivalents and marketable securities as of December 31, 2024, were $36.1 million, compared [Read more]